Bharat biotech international ltd, Biotechnology company

WHO Chief Scientist Soumya Swaminathan on Wednesday congratulated India after the World Health Organisation (WHO) granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin."One more vaccine gets @WHO emergency use listing. Congratulations India @BharatBiotech@ICMRDELHI @MoHFW_INDIA for successful development of indigenous vaccine #Covaxin as well as for a massive vaccination program," the WHO Chief Scientist tweeted.The WHO has issued an emergency use listing (EUL) for India's indigenous vaccine Covaxin, adding to a growing portfolio of vaccines validated by WHO for prevention of COVID-19.The WHO said in a tweet that the Technical Advisory Group, convened by World Health Organisation (WHO), has determined that the Hyderabad-based Bharat Biotech's COVID-19 vaccine meets WHO standards for protection against COVID-19."WHO has granted emergency use listing (EUL) to COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19," WHO said in a tweet."The Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the Covaxin vaccine meets WHO standards for protection against #COVID19, that the benefit of the vaccine far outweighs risks and the vaccine can be used," it added.The global health body said that the Covaxin vaccine was also reviewed by WHO's Strategic Advisory Group of Experts on Immunization (SAGE), and recommended the use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above.Earlier, the WHO panel had sought additional clarifications from the manufacturer of Covaxin, in order to conduct a final EUL risk-benefit assessment for global use of the vaccine.Bharat Biotech's Covaxin and AstraZeneca and Serum Institute's Covishield are two widely used vaccines in India against COVID-19. WHO has so far approved COVID-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson 7 Johnson - Janssen, Moderna, and Sinopharm for emergency use.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Bharat Biotech International LtdFOLLOW

Bharat biotech international ltd, Latest News

New Delhi, Nov 9 Hyderabad-based pharma major Bharat Biotech's Covid vaccine Covaxin will be added to the UK ... ...

The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine for children, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said. ...

New Delhi, Nov 6 Hyderabad-based pharma major Bharat Biotech's US partner Ocugen has sought the Emergency Use Authorisation ... ...

Bharat Biotech's US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18. ...

Following the World Health Organization's (WHO) Emergency Use Listing (EUL) for Bharat Biotech's COVID-19 vaccine, Covaxin, Indian Council of Medical Research (ICMR) Director General Balram Bhargava on Wednesday said the approval has now opened up th ...

Vice President M Venkaiah Naidu on Wednesday congratulated Bharat Biotech and ICMR for developing Covaxin which got World Health Organization's (WHO) nod for emergency use on Wednesday. ...

Hyderabad, Nov 3 The Hyderabad-based Bharat Biotech announced on Wednesday that the World Health Organisation (WHO) has franted ... ...

WHO Chief Scientist Soumya Swaminathan on Wednesday congratulated India after the World Health Organisation (WHO) granted approval for Emergency Use Listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine, Covaxin. ...